The antibody drug conjugate didn’t help patients live longer in a confirmatory trial, prompting a review of its conditional approval.

Liverpool ONE will bring all things fantastic and frightful at the Halloween Street Party this October, including a ...

Smoking is a bad habit yes but there are too many smokers who ignore the health warning. We bring to you this list of 11 ...

BioNTech (NASDAQ:BNTX) shares fell Friday after the company said it had been informed by partner OncoC4 that FDA placed ...

The move is a blow to Gilead’s cancer portfolio. Trodelvy, an antibody-drug conjugate granted accelerated approval for ...

The current research focus for Umit Tapan, MD, Boston Medical Center, is reducing disparities in lung cancer care and ...

Trodelvy’s next big readout is EVOKE-03, which is testing the Gilead drug with Merck’s PD-1 inhibitor Keytruda in PD-L1-high ...

Dr. Kurdi received his Medical Degree with honors from The Faculty of Medicine of Damascus University. Dr. Kurdi also completed his residency at St. Joseph Mercy Hospital, Oakland, MI, a fellowship in ...

Gilead in 2021 won the FDA accelerated nod for Trodelvy in metastatic urothelial cancer, but continued approval was contingent on the outcome of a confirmatory study. The company in late May said that ...

Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the ...

Panelists discuss how biomarker testing is currently utilized in the management of patients with small cell lung cancer (SCLC), including its timing within the treatment journey, while also exploring ...

However, alongside these accolades, Iowa has been climbing the ranks in two more alarming categories: obesity and cancer.